Role of PCA3 and SelectMDx in the optimization of active surveillance in prostate cancer
Volume: 45, Issue: 6, Pages: 439 - 446
Published: Jul 1, 2021
Abstract
A not negligible percentage of patients included in active surveillance (AS) for low and very low risk prostate cancer (PCa) are reclassified in the confirmatory biopsy or have disease progression during follow-up. Our aim is to evaluate the role of PCA3 and SelectMDx, in an individual and combined way, in the prediction of pathological progression (PP) in a standard AS program. Prospective and observational study comprised of 86 patients...
Paper Details
Title
Role of PCA3 and SelectMDx in the optimization of active surveillance in prostate cancer
Published Date
Jul 1, 2021
Volume
45
Issue
6
Pages
439 - 446
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History